3LS-28190-30423

3 vaccinations 14 coded responses 28 check-ins 14 free-text entries 1 call case

Sex: Female
Age at first dose: 41-45
ZIP prefix: 040 / ME
Registered: 2021-03-19

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-19
Registered in v-safe
2021-03-19
Dose 1 — Janssen/Johnson & Johnson
2021-03-19
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-03-20
Survey response — days 1–6 daily, dose 1
MedDRA: Heart rate increased, Hyperhidrosis, Lymphadenopathy — Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activities

Free text: Sweats, pain in armpit glands, rapid resting heart rate

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-21
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fever · Headache · Be unable to do your normal daily activities

Adult check-in
2021-03-22
Survey response — days 1–6 daily, dose 1
MedDRA: Dysarthria — Feeling: Fair · Headache · Be unable to do your normal daily activities

Free text: Speech slushy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-23
Survey response — days 1–6 daily, dose 1
MedDRA: Speech disorder — Feeling: Good · Headache

Free text: Speech issues

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-24
Survey response — days 1–6 daily, dose 1
MedDRA: Dysphagia, Speech disorder — Feeling: Fair · Be unable to do your normal daily activities

Free text: Speech and swallow difficulties

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-25
Survey response — days 1–6 daily, dose 1
MedDRA: Dysphagia, Speech disorder — Feeling: Good · Be unable to do your normal daily activities

Free text: Speech and swallowing difficulties

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-26
Survey response — day 7, dose 1
MedDRA: Dysphagia, Gait disturbance, Speech disorder — Feeling: Good · Be unable to do your normal daily activities

Free text: Difficulty with speech, swallow and walk

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-02
Survey response — day 14, dose 1
MedDRA: Neurological symptom — Feeling: Good

Free text: Neurological symptoms increased but have held steady last few days

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-09
Health check-in — day 21, single dose
Feeling: Fair

Adult check-in
2021-04-16
Survey response — day 28, single dose
MedDRA: Migraine — Feeling: Good

Free text: Visual migraines

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-23
Survey response — day 35, single dose
MedDRA: Unevaluable event — Feeling: Good

Free text: I dont have antibodies 5 weeks out per quest lab test

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-30
Survey response — day 42, single dose
MedDRA: Unevaluable event — Feeling: Good

Free text: No antibodies to vaccine. Not protected.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-20
Survey response — 3 months, dose 1
MedDRA: Condition aggravated, Pre-existing disease, SARS-CoV-2 antibody test negative — Feeling: Good

Free text: No antibodies found. Flared neurological symptoms

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-09-19
Survey response — 6 months, dose 1
MedDRA: Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: It did not work. How many times to I need to tell you I have no immunity from the J&J vaccine and have to try another one.

MedDRA releases: 2024-11 · check-in free text available
2021-09-19
Report sent to call center — 6 months, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2021-09-22
Call successful
Completed over the phone
2021-10-07
Dose 2 — Moderna
2021-11-04
Dose 3 — Moderna
2021-11-04
Health check-in — day 0, dose 3
Feeling: Good · None

Adult check-in
2021-11-05
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Headache, Joint pains

Adult check-in
2021-11-06
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-07
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-09
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-11
Survey response — day 7, dose 3
MedDRA: Dysarthria, Nervous system disorder — Feeling: Good

Free text: Neurological issues like speech slurring.

MedDRA releases: 2024-11 · check-in free text available
2021-11-18
Survey response — day 14, dose 3
MedDRA: Headache, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Worst headache, speech, walking and hand usage.

MedDRA releases: 2024-11 · check-in free text available
2021-11-25
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-12-02
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-12-11
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-12-16
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-02-03
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-11-06
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-19	Janssen/Johnson & Johnson
2	2021-10-07	Moderna	No
3	2021-11-04	Moderna	No

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-20

Systemic reaction (other): Sweats, pain in armpit glands, rapid resting heart rate

2021-03-22

Systemic reaction (other): Speech slushy

2021-03-23

Systemic reaction (other): Speech issues

2021-03-24

Systemic reaction (other): Speech and swallow difficulties

2021-03-25

Systemic reaction (other): Speech and swallowing difficulties

Release 6 — day 7, dose 1

2021-03-26

Systemic reaction (other): Difficulty with speech, swallow and walk

Release 6 — day 14, dose 1

2021-04-02

Symptoms: Neurological symptoms increased but have held steady last few days

Release 7 — day 28, single dose

2021-04-16

Symptoms: Visual migraines

Release 7 — day 35, single dose

2021-04-23

Symptoms: I dont have antibodies 5 weeks out per quest lab test

Release 8 — day 42, single dose

2021-04-30

Symptoms: No antibodies to vaccine. Not protected.

Release 9 — 3 months, dose 1

2021-06-20

Symptoms: No antibodies found. Flared neurological symptoms

Release 9 — 6 months, dose 1

2021-09-19

Symptoms: It did not work. How many times to I need to tell you I have no immunity from the J&J vaccine and have to try another one.

Release 10 — day 7, dose 3

2021-11-11

Systemic reaction (other): Neurological issues like speech slurring.

Release 10 — day 14, dose 3

2021-11-18

Symptoms: Worst headache, speech, walking and hand usage.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Condition aggravated	✓	✓	✓
SD	Headache	·	·	✓
SD	Migraine	✓	✓	✓
SD	Neurological symptom	✓	✓	✓
SD	Pre-existing disease	✓	✓	✓
SD	SARS-CoV-2 antibody test negative	✓	✓	✓
SD	Unevaluable event	✓	✓	✓
SRO	Dysarthria	✓	✓	✓
SRO	Dysphagia	✓	✓	✓
SRO	Gait disturbance	✓	✓	✓
SRO	Heart rate increased	✓	✓	✓
SRO	Hyperhidrosis	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓
SRO	Nervous system disorder	·	·	✓
SRO	Speech disorder	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release